Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ozari Health vs Remedy Meds

Ozari Health
Graded #136

Higher grade

vs+13.300000000000004
Remedy Meds
Graded #436

Lower grade

The verdict

Ozari Health takes it — 68.9/100 to 55.6/100.

Ozari Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ozari Health is a telehealth weight-loss platform selling physician-prescribed compounded GLP-1 from licensed 503A/503B pharmacies.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOzari Health +39
75
36
Dose & formulationEven
64
64
Clinical oversightOzari Health +5
79
74
Labs & monitoringRemedy Meds +1
52
53
FulfillmentOzari Health +18
83
65
Contract termsOzari Health +6
47
41
Ozari Health · left barRemedy Meds · right bar

The numbers

MetricOzari HealthRemedy Meds
WeighScore68.9/10055.6/100
GradeCC
Scorecard rank#136#436
Semaglutide$86/mo (3-mo starter plan, new patients only, compounded)$299/mo (starting dose, compounded)
Tirzepatide$125/mo (3-mo starter plan, new patients only, compounded)$399/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Ozari Health

Graded #136 · C

Strengths

  • Very low entry pricing — compounded semaglutide from $86/month
  • LegitScript certified and operated by a named entity (Ozari LLC)
  • Board-certified physicians; meds compounded in 503A and 503B facilities
  • Shipping included in the plan price

Where it loses points

  • The advertised rates are three-month starter plans for first-time GLP-1 users, billed $257 and $375 up front; month-to-month is $175 and $235
  • Cancelling an annual or semi-annual plan early re-prices the installments already shipped at the standard monthly rate and charges the difference
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Remedy Meds

Graded #436 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard